Literature DB >> 8453960

Variation in the binding affinity of warfarin and phenprocoumon to human serum albumin in relation to surgery.

H Vorum1, H R Jørgensen, R Brodersen.   

Abstract

The binding equilibria of warfarin and phenprocoumon with defatted human serum albumin were studied by equilibrium dialysis in 33 mM sodium phosphate buffer, pH 7.4, 37 degrees C. The binding isotherms for both ligands were consistent with binding to two similar and independent sites in the albumin molecule. The binding affinity of warfarin was markedly increased on adding palmitic acid up to palmitate 4 mol per mol albumin and then it decreased. The binding affinity of phenprocoumon varied similarly but to a lesser degree. Serum samples were obtained from 14 patients undergoing knee joint surgery, six consecutive samples from each patient. The binding affinity of warfarin and phenprocoumon added in low concentrations to the serum samples was consistently less than to purified albumin. The binding affinity for warfarin increased slightly with increasing fatty acid concentrations during surgery, but the increase was much less than expected from the in vitro studies. The binding of phenprocoumon in the serum samples was not influenced by changing fatty acid concentration. The binding affinity for both drugs decreased markedly during the three days following surgery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453960     DOI: 10.1007/bf00315474

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  28 in total

1.  Warfarin binding to plasma albumin, measured in patients and related to fatty acid concentrations.

Authors:  F G Larsen; C G Larsen; S Andersen; A Nørgaard; H E Hansen; R Brodersen
Journal:  Eur J Clin Invest       Date:  1986-02       Impact factor: 4.686

2.  Effect of in vivo elevation of free fatty acids on protein binding of drugs.

Authors:  R Gugler; D W Shoeman; D L Azarnoff
Journal:  Pharmacology       Date:  1974       Impact factor: 2.547

3.  Drug inhibition of catecholamine-induced metabolic effects in humans.

Authors:  D B Hunninghake; D L Azarnoff; D Waxman
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

4.  Interaction of warfarin with human serum albumin. A stoichiometric description.

Authors:  F G Larsen; C G Larsen; P Jakobsen; R Brodersen
Journal:  Mol Pharmacol       Date:  1985-02       Impact factor: 4.436

5.  Multiple competitive displacement interactions involving human serum albumin, anticoagulants, oleic acid and various drugs.

Authors:  W D Wosilait; M P Ryan
Journal:  Gen Pharmacol       Date:  1980

6.  Determination of reserve albumin-equivalent for ligand binding, probing two distinct binding functions of the protein.

Authors:  R Brodersen; S Andersen; C Jacobsen; O Sønderskov; F Ebbesen; W J Cashore; S Larsen
Journal:  Anal Biochem       Date:  1982-04       Impact factor: 3.365

7.  Influence of palmitate and oleate on the binding of warfarin to human serum albumin: stopped-flow studies.

Authors:  N Rietbrock; G Menke; G Reuter; A Lassmann; R Schmeidl
Journal:  J Clin Chem Clin Biochem       Date:  1985-11

8.  The displacement of phenylbutazone-14C and warfarin-14C from human albumin by various drugs and fatty acids.

Authors:  H M Solomon; J J Schrogie; D Williams
Journal:  Biochem Pharmacol       Date:  1968-01       Impact factor: 5.858

9.  Influence of long-chain free fatty acids on the binding of waraarin to bovine serum albumin.

Authors:  S Chakrabarti; R Laliberté; J Brodeur
Journal:  Biochem Pharmacol       Date:  1976-11-15       Impact factor: 5.858

10.  Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Authors:  A Yacobi; J A Udall; G Levy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

View more
  4 in total

1.  Calculation of normalized drug concentrations in the presence of altered plasma protein binding.

Authors:  Florin Marcel Musteata
Journal:  Clin Pharmacokinet       Date:  2012-01-01       Impact factor: 6.447

Review 2.  The role of the protein-binding on the mode of drug action as well the interactions with other drugs.

Authors:  Christine Tesseromatis; Anastasia Alevizou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

3.  Influence of halothane anaesthesia on protein binding of drugs.

Authors:  R Calvo; E Suárez; L Aguilera; J M Rodríguez Sasiaín
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  Anticoagulant-induced changes on antibiotic concentrations in the serum and bones.

Authors:  A Kotsiou; E Diamanti; A Potamianou; H Parara; J Vovou; C Perisanidis; C Tes; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Jul-Sep       Impact factor: 2.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.